A detailed history of Nisa Investment Advisors, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 2,569 shares of BCRX stock, worth $19,704. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,569
Previous 2,093 22.74%
Holding current value
$19,704
Previous $12,000 58.33%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$6.41 - $8.69 $3,051 - $4,136
476 Added 22.74%
2,569 $19,000
Q2 2024

Jul 19, 2024

BUY
$4.13 - $6.79 $12 - $20
3 Added 0.14%
2,093 $12,000
Q1 2024

May 01, 2024

BUY
$4.89 - $7.65 $880 - $1,377
180 Added 9.42%
2,090 $10,000
Q4 2023

Jan 25, 2024

SELL
$4.98 - $6.77 $17,006 - $23,119
-3,415 Reduced 64.13%
1,910 $11,000
Q3 2023

Nov 02, 2023

BUY
$6.71 - $7.92 $228 - $269
34 Added 0.64%
5,325 $37,000
Q2 2023

Aug 11, 2023

BUY
$6.96 - $8.81 $23,462 - $29,698
3,371 Added 175.57%
5,291 $37,000
Q1 2023

May 02, 2023

SELL
$7.94 - $11.84 $35,174 - $52,451
-4,430 Reduced 69.76%
1,920 $16,000
Q4 2022

Feb 02, 2023

BUY
$10.5 - $14.2 $115 - $156
11 Added 0.17%
6,350 $73,000
Q3 2022

Nov 07, 2022

BUY
$10.79 - $14.81 $1,391 - $1,910
129 Added 2.08%
6,339 $85,000
Q1 2022

Apr 29, 2022

SELL
$11.56 - $19.76 $8,438 - $14,424
-730 Reduced 10.52%
6,210 $101,000
Q4 2021

Feb 03, 2022

SELL
$11.18 - $15.46 $50,980 - $70,497
-4,560 Reduced 39.65%
6,940 $107,000
Q2 2021

Aug 06, 2021

SELL
$9.5 - $17.24 $4,037 - $7,326
-425 Reduced 3.56%
11,500 $182,000
Q1 2021

Apr 26, 2021

BUY
$7.37 - $13.61 $66,330 - $122,490
9,000 Added 307.69%
11,925 $121,000
Q4 2020

Jan 25, 2021

BUY
$3.37 - $8.61 $2,864 - $7,318
850 Added 40.96%
2,925 $22,000
Q2 2020

Jul 27, 2020

BUY
$1.9 - $5.61 $199 - $589
105 Added 5.33%
2,075 $10,000
Q1 2020

Apr 17, 2020

BUY
$1.6 - $4.11 $3,152 - $8,096
1,970 New
1,970 $4,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.43B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.